Skip to main content

Advertisement

SpringerLink
  • Science China Life Sciences
  • Journal Aims and Scope
  • Submit to this journal
Potential clinical treatment for Ebola pandemic
Download PDF
Download PDF
  • Insight
  • Open Access
  • Published: 19 September 2014

Potential clinical treatment for Ebola pandemic

  • Ying Zhong1,
  • Jun Xu2,
  • TaiSheng Li3,
  • XueZhong Yu2 &
  • …
  • MiaoMiao Sheng4 

Science China Life Sciences volume 57, pages 982–984 (2014)Cite this article

  • 1915 Accesses

  • 3 Citations

  • 2 Altmetric

  • Metrics details

Download to read the full article text

Working on a manuscript?

Avoid the most common mistakes and prepare your manuscript for journal editors.

Learn more

References

  1. Geisbert TW, Hensley LE, Jahrling PB, Larsen T, Geisbert JB, Paragas J, Young HA, Fredeking TM, Rote WE, Vlasuk GP. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet, 2003, 362: 1953–1958

    Article  PubMed  CAS  Google Scholar 

  2. Oestereich L, Ludtke A, Wurr S, Rieger T, Munoz-Fontela C, Gunther S. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Res, 2014, 105: 17–21

    Article  PubMed  CAS  Google Scholar 

  3. Warren TK, Wells J, Panchal RG, Stuthman KS, Garza NL, Van Tongeren SA, Dong L, Retterer CJ, Eaton BP, Pegoraro G, Honnold S, Bantia S, Kotian P, Chen X, Taubenheim BR, Welch LS, Minning DM, Babu YS, Sheridan WP, Bavari S. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature, 2014, 508: 402–405

    Article  PubMed  CAS  Google Scholar 

  4. Olinger GG, Jr., Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly M, Whaley KJ, Lear CM, Biggins JE, Scully C, Hensley L, Zeitlin L. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci USA, 2012, 109: 18030–18035

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  5. Warren TK, Warfield KL, Wells J, Swenson DL, Donner KS, Van Tongeren SA, Garza NL, Dong L, Mourich DV, Crumley S, Nichols DK, Iversen PL, Bavari S. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat Med, 2010, 16: 991–994

    Article  PubMed  CAS  Google Scholar 

  6. Uebelhoer LS, Albarino CG, McMullan LK, Chakrabarti AK, Vincent JP, Nichol ST, Towner JS. High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses. Antiviral Res, 2014, 106: 86–94

    Article  PubMed  CAS  Google Scholar 

  7. Johansen LM, Brannan JM, Delos SE, Shoemaker CJ, Stossel A, Lear C, Hoffstrom BG, Dewald LE, Schornberg KL, Scully C, Lehar J, Hensley LE, White JM, Olinger GG. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Sci Translat Med, 2013, 5: 190ra179

    Google Scholar 

  8. Gehring G, Rohrmann K, Atenchong N, Mittler E, Becker S, Dahlmann F, Pohlmann S, Vondran FW, David S, Manns MP, Ciesek S, von Hahn T. The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry. J Antimicrob Chemother, 2014, 69: 2123–2131

    Article  PubMed  CAS  Google Scholar 

  9. Dokuzoguz B, Celikbas AK, Gok SE, Baykam N, Eroglu MN, Ergonul O. Severity scoring index for crimean-congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin Infect Dis, 2013, 57: 1270–1274

    Article  PubMed  CAS  Google Scholar 

  10. Lee W, Ku SK, Bae JS. Barrier protective effects of rutin in LPS-induced inflammation in vitro and in vivo. Food Chem Toxicol, 2012, 50: 3048–3055

    Article  PubMed  CAS  Google Scholar 

  11. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res, 2004, 64: 145–160

    Article  PubMed  CAS  Google Scholar 

  12. May JM, Harrison FE. Role of vitamin C in the function of the vascular endothelium. Antioxid Redox Signal, 2013, 19: 2068–2083

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  13. Sharifi-Mood B, Alavi-Naini R, Metanat M, Mohammadi M, Shakeri A, Amjadi A. Efficacy of high-dose methylprednisolone in patients with Crimean-Congo haemorrhagic fever and severe thrombocytopenia. Trop Doct, 2013, 43: 49–53

    Article  PubMed  Google Scholar 

  14. Patel JM, Snaith C, Thickett DR, Linhartova L, Melody T, Hawkey P, Barnett AH, Jones A, Hong T, Cooke MW, Perkins GD, Gao F. Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (asepsis trial). Crit Care, 2012, 16: R231

    Article  PubMed  PubMed Central  Google Scholar 

  15. Undas A, Brummel-Ziedins KE, Mann KG. Anticoagulant effects of statins and their clinical implications. Thromb Haemost, 2014, 111: 392–400

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences; Department of Biochemistry and Molecular Biology, Peking Union Medical College, Tsinghua University, Beijing, 100005, China

    Ying Zhong

  2. Department of Emergency Medicine, Peking Union Medical Collage Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China

    Jun Xu & XueZhong Yu

  3. Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China

    TaiSheng Li

  4. Laboratory of Molecular Genetics of Aging & Tumor, Medical Faculty, Kunming University of Science and Technology, Chenggong Campus, Kunming, 650500, China

    MiaoMiao Sheng

Authors
  1. Ying Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. TaiSheng Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. XueZhong Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. MiaoMiao Sheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to MiaoMiao Sheng.

Additional information

This article is published with open access at link.springer.com

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhong, Y., Xu, J., Li, T. et al. Potential clinical treatment for Ebola pandemic. Sci. China Life Sci. 57, 982–984 (2014). https://doi.org/10.1007/s11427-014-4756-5

Download citation

  • Received: 14 September 2014

  • Accepted: 17 September 2014

  • Published: 19 September 2014

  • Issue Date: October 2014

  • DOI: https://doi.org/10.1007/s11427-014-4756-5

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Dronedarone
  • West African Country
  • Phosphorodiamidate Morpholino
  • Epidemic Hemorrhagic Fever
  • Vascular Barrier Integrity
Download PDF

Working on a manuscript?

Avoid the most common mistakes and prepare your manuscript for journal editors.

Learn more

Advertisement

Over 10 million scientific documents at your fingertips

Switch Edition
  • Academic Edition
  • Corporate Edition
  • Home
  • Impressum
  • Legal information
  • Privacy statement
  • California Privacy Statement
  • How we use cookies
  • Manage cookies/Do not sell my data
  • Accessibility
  • FAQ
  • Contact us
  • Affiliate program

Not affiliated

Springer Nature

© 2023 Springer Nature Switzerland AG. Part of Springer Nature.